Trademark Search / X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
○ Dead · CancelledU.S. federal trademark · Serial No. 79006517 · Reg. No. 3283161
Mark
X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
Filing Date
September 21, 2004
Registration Date
August 21, 2007
Class(es)
Class 005, Class 042, Class 044
Goods & Services
Pharmacological consulting services; pharmaceutical and medical information services
Scientific research services for medical purposes, namely clinical studies in the field of hypertension
Pharmaceutical preparation, namely an anti-hypertensive preparation
Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS" or anything like it, before you file.
Run a free trademark search →Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.